Animal Model Market Analysis and Forecast 2032: By Animal Type (Rat, Mice, Guinea Pigs, Rabbits, Others), Application (Cancer, Immunological Disease, Infectious Disease, Others), End User (Pharmaceutical & Biotechnology Companies, Academic Research Institute, Contract Research Organization), and Region
The Animal Model Market was valued at US$ 1.9 billion in 2022 and it is anticipated to grow up to US$ 3.6 billion by 2032, at a CAGR of 6.6% during the forecast period.
Non-human organisms, usually animals, are employed in scientific research to examine biological processes, discover disease causes, create new therapies, and gain knowledge about human health and physiology. Animal models are important in many domains, including medicine, pharmacology, genetics, and toxicity. They enable researchers to comprehend complicated biological systems, test ideas, and make forecasts before proceeding to human trials.
Animal Model Market Scope and Report Structure
| Report Attribute | Details |
|---|---|
| Market Size in 2022 | $1.9 bn |
| Market Size in 2032 | $3.6 bn |
| Growth Rate (2023-32) | 6.6% |
| Historic Period | 2016-2021 |
| Forecast Period | 2023-2032 |
| Base Year | 2022 |
| Segments Covered | Animal Type, Application, End-User, and Region |
| Key Companies | The Jackson Laboratory, Charles River Laboratories, Crown Bioscience Inc., Janvier Labs, Hera Biolabs, Taconic Biosciences, Genoway S.A., Inotiv, Inc., Ozgene Pty Ltd., and BioSpherix, Ltd. among others |
| Regional Scope | North America, Europe, Asia Pacific, Central & South America, Middle East & Africa |
| Analysis Coverage | Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments |
Market Drivers and Trends
Rise in the usage of the animal models in virology is driving the market expansion. Animal models, including mice, rats, guinea pigs, and nonhuman primates, are critical in investigating the pathophysiology, transmission, and potential therapies for a variety of viral infections and infectious illnesses. These models provide a crucial platform for researchers to better understand the intricate mechanisms of viral replication, host immune responses, and disease development. Animal models have been found to be invaluable tools in virology research, enabling scientists to simulate human illnesses and evaluate the efficiency of antiviral medicines and vaccinations. In the instance of the COVID-19 pandemic, for example, animal models were critical in comprehending the SARS-CoV-2 virus and assessing prospective treatment strategies. Researchers to explore viral entrance, replicating, and dissemination, as well as to evaluate vaccine candidates and antiviral medicines utilized animal models. These studies shed light on the virus’s behaviour and aided in the development of efficient preventative and treatment measures.
Additionally, increase in the CRISPR technology is going to boost the market growth in the coming years. CRISPR allows scientists to modify individual genes in animals with remarkable accuracy, resulting in more precise disease models. Scientists can imitate the genetic abnormalities found in patients by introducing particular mutations linked with human illnesses into animal genomes, allowing for a deeper understanding of disease processes and the evaluation of prospective therapeutic approaches. CRISPR, for example, has been used to investigate cancer, based on a 2022 report by the National Library of Medicine, since the approach offers various new methods to mimic the illness. This involves the creation of pre-clinical cancer models in which CRISPR is used to produce mutations found in human cancer. As a result, rare mutations may be examined in a physiologically appropriate context, and CRISPR technology has sped up the development of these models. CRISPR technology developers Emmanuelle Charpentier and Jennifer Doudna were awarded the Nobel Prize in 2020. These drivers are likely to propel market expansion.
Market Restraints and Challenges
To ensure the ethical and appropriate application of animals in scientific research, strict regulatory criteria for animal model utilization are in place. To protect animal welfare, a structure of strong regulations and rigid norms exists. These restrictions are extensive and differ from one country to the next. Typically, regulatory requirements demand that researchers establish the scientific need and possible benefits of utilizing animal models. Institutional animal care and use committees (IACUCs) or equivalent regulatory agencies conduct ethical reviews of research proposals involving animal testing. These committees evaluate the proposed studies’ rationale, design, and welfare issues. Such severe and changeable laws may impede the employing of animal models in scientific research, stifling corporate growth.
Animal Model Market Segmental Overview
The report analyses the Animal Model Market based on animal type, application, end-user, and region.
Animal Model Market by Animal Type
Based on animal type, the Animal Model Market is segmented into rat, mice, guinea pigs, rabbits, and others. The mice segment is expected to dominate the market during the forecast period. Increased investment and technical improvement in mouse model technologies are expected to fuel market expansion. Furthermore, the growing implications of mouse clinical trials for further predicted results, as well as the increasing desire for personalized therapy, are driving up demand for mice models. For example, in March 2023, National Institutes of Health researchers investigated an improved genetic animal model of Down syndrome. The unique mouse model provided prospective treatment possibilities for the illness.
However, The guinea pig category will be the fastest increasing in the future years. Factors such as broad regulatory approval, well-characterized guinea pig strains, and a lack of alternative methodologies are expected to drive segment growth. Furthermore, the unique physiologic properties of guinea pigs render them suited for a wide range of scientific applications. As a result, the aforementioned factors will likely lead to market expansion.
Animal Model Market by Application
By application, the market is classified into cancer, immunological disease, infectious disease, and others. The cancer segment dominated the market in 2022 in terms of revenue and is expected to dominate the market during the forecast period. The market is expected to rise due to factors such as the translational importance of animal models in cancer research, the growing trend of precision oncology, and developments in tumor modeling methodologies. These models are used to assess the safety and effectiveness of anti-cancer treatments in clinical trials and preclinical testing. Furthermore, animal models assist researchers in testing the therapeutic index, bioavailability, and pharmacokinetic features of anti-cancer medicines prior to moving on with human clinical trials. Charles River Laboratories and Creative Biolabs are two firms that provide models for cancer research and treatment development.
The high prevalence of immunological diseases, as well as increased efforts by biopharmaceutical firms to produce treatments for diverse immunological disorders, are driving the immunological disease segment’s rise. Animal models are important for evaluating disease mechanisms, immunological processes, and investigating potential therapeutic methods for the illness.
Animal Model Market by End-User
Based on end-user, the Animal Model Market is segmented into pharmaceutical & biotechnology companies, academic research institute, and contract research organization. In 2022, the pharma and biotech companies segment dominated the market in terms of revenue and is expected to be the same during the upcoming years. Companies’ increased attempts to create innovative treatment regimens are expected to boost the segment’s growth. Additionally, pharmaceutical firms’ increased medication discovery and development operations are contributing to category expansion. Furthermore, a large number of research-driven pharmaceutical businesses and their numerous activities are expected to boost market expansion.
On the other hand, the contract research organization segment is expected to develop at the quickest rate throughout the projection period. Due to time and cost limitations, the desire for outsourcing operations, as well as increased investment in R&D programs, are significant drivers expected to fuel market expansion in the future years. Contract research outsourcing alliances provide cutting-edge services, and as a result, government organizations prefer awarding projects to contract research organizations, boosting industry growth.
Regional Analysis of the Animal Model Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America has the biggest market share in terms of Animal Model Market value followed by Asia Pacific. The presence of significant companies and many strategic efforts by them are attributed to the region’s growth. Furthermore, expanding biomedical research and clinical trial spending are driving regional market expansion. Furthermore, advances in genetic modification and the increasing use of animal-based models for drug profiling and characterization are projected to open up new opportunities for market expansion.
The Asia-Pacific Animal Model Market is predicted to expand the fastest during the forecast period. The high illness burden of chronic diseases that include cancer, immunological disorders, and uncommon genetic disorders is expected to drive regional market expansion. Furthermore, large expenditures made by important companies in the region, together with favorable government laws for studies, are another driver driving regional market expansion.
Major Players in the Animal Model Market
The key players studied in the Animal Model Market are The Jackson Laboratory, Charles River Laboratories, Crown Bioscience Inc., Janvier Labs, Hera Biolabs, Taconic Biosciences, Genoway S.A., Inotiv, Inc., Ozgene Pty Ltd., and BioSpherix, Ltd. among others.
COVID-19 Impact
The introduction of COVID-19 was a historic public health problem that benefited the animal model industry. The rising incidence of COVID-19 patients also had a significant impact on the healthcare system. Despite the pandemic, large investments in COVID-19 research and increasing financing for R&D efforts to design innovative therapies have boosted the use of animal models. Taconic Biosciences, for example, announced the release of a new COVID-19 mouse model in April 2021. Taconic’s COVID-19 research package now includes a human ACE2 (hACE2) transgenic mouse. When compared to deadly infection models, the hACE2 AC22 mouse allows for a longer research window to test medication effectiveness.
Several pharmaceutical, biotechnology, and clinical research organizations have increased their R&D investment to focus on the pandemic. To explore COVID-19 infection, several animal models are being examined and used. Mice, particularly SARS-CoV-2 strain acclimated mice following purposeful viral passaging in lung tissues, were widely used in infectious illness research. The aforementioned component had a favorable influence during the COVID-19 pandemic.
Recent Developments
- In January 2023, Charles River Laboratories has announced the addition of two additional NCG mice strains to their triple-immunodeficient mouse model portfolio, which are best suited for investigations in cancer, immunology, and infectious diseases.
- In November 2022, Charles River Laboratories stated that it has inked a deal with Hera BioLabs to breed, distribute, market, and sell the SRG rat for use by the global preclinical research community.
- In September 2022, Genoway S.A. and Sigma-Aldrich Co LLC established a new framework for their 2018 CRISPR/Cas9 strategic collaboration. GenOway will continue to spearhead the commercialization of Sigma-Aldrich’s CRISPR patent property in rodent species.
- In June 2021, Genoway S.A. has announced a non-exclusive licence arrangement with ERS Genomics Limited. The arrangement gives GenOway access to ERS Genomics’ CRISPR/Cas9 patent portfolio in the past and in the future.
- In December 2020, Genoway S.A. has established a strategic collaboration with Cyagen to commercialise high-quality preclinical humanised immune checkpoint and immunodeficient BRGSF mice models to charity and for-profit organisations in Asia-Pacific beginning in 2020.
Animal Model Market Report Coverage
- The report offers a comprehensive quantitative as well as qualitative analysis of the current Animal Model Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
- The report also covers qualitative as well as quantitative analysis of Animal Model Market in terms of revenue ($Billion).
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Animal Model industry.
- A thorough analysis of market trends and restraints is provided.
- By region as well as country market analysis is also presented in this report.
- Analytical depiction of the Animal Model Market along with the current trends and future estimations to depict imminent investment pockets. The overall Animal Model industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
- Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Animal Model Market are also analyzed.
Frequently Asked Questions
Q1. How big is the Animal Model Market?
Ans. The Animal Model Market size was US$ 1.9 billion in 2022 and is anticipated to reach US$ 3.6 billion in 2032, growing at a rate of 6.6% from 2022 to 2032.
Q2. What is the Animal Model Market growth rate?
Ans. The growth rate of the Animal Model Market is 6.6% from 2022 to 2032.
Q3. Which region holds a major market share for the Animal Model Market?
Ans. North America holds a major market share of the Animal Model Market in 2022.
Q4. Which segment accounted for the largest Animal Model Market share?
Ans. Based on animal type, the Animal Model Market is segmented into rat, mice, guinea pigs, rabbits, and others. The mice segment is expected to dominate the market during the forecast period.
Q5. Who are the key players in the Animal Model Market?
Ans. The Animal Model Market report includes players such as The Jackson Laboratory, Charles River Laboratories, Crown Bioscience Inc., Janvier Labs, Hera Biolabs, Taconic Biosciences, Genoway S.A., Inotiv, Inc., Ozgene Pty Ltd., and BioSpherix, Ltd. among others.
Q6. What are the factors driving the Animal Model Market growth?
Ans. The major factor driving the growth of the market is the rise in the use of animal models in virology and increase in the adoption of CRISPR technology.
Q7. What are the key growth strategies of Animal Model Market players?
Ans. The key growth strategies of Animal Model Market players are product launch, partnerships, and government initiatives.
Q8. Which region will provide more business opportunities for the Animal Model Market during the forecast period?
Ans. The North America region will provide more business opportunities for the Animal Model Market during the forecast period.
Table of Contents
Chapter 1. Animal Model Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, By Region
3.2. Market Attractiveness Analysis, By Animal Type
3.3. Market Attractiveness Analysis, By Application
3.4. Market Attractiveness Analysis, By End-User
Chapter 4. Animal Model Market Outlook
4.1. Animal Model Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.5.1. Raw End User Vertical Suppliers
4.5.2. Manufacturers
4.5.3. Wholesalers and/or Retailers
4.6. Impact of COVID-19 on the Animal Model Market
4.7. Impact of the Russia and Ukraine War on the Animal Model Market
Chapter 5. Animal Model Market By Animal Type
5.1. Market Overview
5.2. Rat
5.2.1. Market Size And Forecast, 2022-2032 ($Million)
5.2.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
5.3. Mice
5.3.1. Market Size And Forecast, 2022-2032 ($Million)
5.3.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
5.4. Guinea Pigs
5.4.1. Market Size And Forecast, 2022-2032 ($Million)
5.4.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
5.5. Rabbits
5.5.1. Market Size And Forecast, 2022-2032 ($Million)
5.5.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
5.6. Others
5.6.1. Market Size And Forecast, 2022-2032 ($Million)
5.6.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
Chapter 6. Animal Model Market By Application
6.1. Market Overview
6.2. Cancer
6.2.1. Market Size And Forecast, 2022-2032 ($Million)
6.2.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
6.3. Immunological Disease
6.3.1. Market Size And Forecast, 2022-2032 ($Million)
6.3.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
6.4. Infectious Disease
6.4.1. Market Size And Forecast, 2022-2032 ($Million)
6.4.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
6.5. Others
6.5.1. Market Size And Forecast, 2022-2032 ($Million)
6.5.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
Chapter 7. Animal Model Market By End-User
7.1. Market Overview
7.2. Pharmaceutical and Biotechnology Companies
7.2.1. Market Size And Forecast, 2022-2032 ($Million)
7.2.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
7.3. Academic Research Institute
7.3.1. Market Size And Forecast, 2022-2032 ($Million)
7.3.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
7.4. Contract Research Organization
7.4.1. Market Size And Forecast, 2022-2032 ($Million)
7.4.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
Chapter 8. Multi-Cloud Management Market, By Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends And Opportunities
8.2.2. North America Animal Model Market Size And Forecast By Animal Type, 2022-2032, ($Million)
8.2.3. North America Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.2.4. North America Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.2.5. North America Animal Model Market Size And Forecast by Country, 2022-2032, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.2.6.2. The U.S. Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.2.6.3. U.S. Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.2.7. Canada
8.2.7.1. Canada Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.2.7.2. Canada Animal Model Market Size And Forecast By Application Concentrators, 2022-2032, ($Million)
8.2.7.3. Canada Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.2.8.2. Mexico Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.2.8.3. Mexico Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3. Europe
8.3.1. Key Market Trends And Opportunities
8.3.2. Europe Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.3. Europe Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.4. Europe Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.5. Europe Animal Model Market Size And Forecast by Country, 2022-2032, ($Million)
8.3.6. Germany
8.3.6.1. Germany Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.6.2. Germany Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.6.3. Germany Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.7. France
8.3.7.1. France Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.7.2. France Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.7.3. France Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.8. U.K
8.3.8.1. U.K. Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.8.2. U.K. Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.8.3. U.K. Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.9. Spain
8.3.9.1. Spain Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.9.2. Spain Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.9.3. Spain Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.10. Italy
8.3.10.1. Italy Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.10.2. Italy Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.10.3. Italy Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.11. Russia
8.3.11.1. Russia Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.11.2. Russia Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.11.3. Russia Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.12. Netherlands
8.3.12.1. Russia Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.12.2. Russia Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.12.3. Russia Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.13. Denmark
8.3.13.1. Russia Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.13.2. Russia Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.13.3. Russia Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.14. Norway
8.3.14.1. Russia Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.14.2. Russia Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.14.3. Russia Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.15. Finland
8.3.15.1. Russia Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.15.2. Russia Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.15.3. Russia Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.16. Sweden
8.3.16.1. Russia Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.16.2. Russia Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.16.3. Russia Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.3.17. Rest of Europe
8.3.17.1. Rest of Europe Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.3.17.2. Rest of Europe Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.3.17.3. Rest of Europe Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends And Opportunities
8.4.2. Asia-Pacific Animal Model Market Size And Forecast by Country, 2022-2032, ($Million)
8.4.3. Asia-Pacific Animal Model Market Size And Forecast By Animal Type, 2022-2032, ($Million)
8.4.4. Asia-Pacific Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.4.5. Asia-Pacific Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.4.6. China
8.4.6.1. China Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.4.6.2. China Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.4.6.3. China Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.4.7. India
8.4.7.1. India Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.4.7.2. India Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.4.7.3. India Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.4.8. Japan
8.4.8.1. Japan Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.4.8.2. Japan Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.4.8.3. Japan Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.4.9.2. South Korea Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.4.9.3. South Korea Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.4.10. Australia
8.4.10.1. China Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.4.10.2. China Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.4.10.3. China Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.4.11. Indonesia
8.4.11.1. China Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.4.11.2. China Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.4.11.3. China Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.4.12. Rest of APAC
8.4.12.1. Rest of APAC Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.4.12.2. Rest of APAC Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.4.12.3. Rest of APAC Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.5. Rest of The World
8.5.1. Key Market Trends And Opportunities
8.5.2. Rest of The World Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.5.3. Rest of The World Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.5.4. Rest of The World Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.5.5. Rest of The World Animal Model Market Size And Forecast by Country, 2022-2032, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.5.6.2. Latin America Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.5.6.3. Latin America Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.5.7.2. Middle East Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.5.7.3. Middle East Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
8.5.8. Africa
8.5.8.1. Africa Animal Model Market Size And Forecast By Animal Type , 2022-2032, ($Million)
8.5.8.2. Africa Animal Model Market Size And Forecast By Application, 2022-2032, ($Million)
8.5.8.3. Africa Animal Model Market Size And Forecast By End-User, 2022-2032, ($Million)
Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Testing Component Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, And Collaborations
9.3.5. Mergers And Acquisitions
Chapter 10. Company Profiles
10.1. The Jackson Laboratory
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Charles River Laboratories
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Crown Bioscience Inc.
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Janvier Labs
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Hera Biolabs
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Taconic Biosciences
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Genoway S.A.
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Inotiv, Inc.
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Ozgene Pty Ltd
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. BioSpherix, Ltd
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis
*The List of Company Is Subject To Change During The Final Compilation of The Report
Key Players
Animal Model Market Segmentation
By Animal Type
- Rat
- Mice
- Guinea pigs
- Rabbits
- Others
By Application
- Cancer
- Immunological Disease
- Infectious Disease
- Others
By End-User
- Pharmaceutical & Biotechnology Companies
- Academic Research Institute
- Contract Research Organization
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The U.K.
- Germany
- France
- Spain
- Italy
- Netherlands
- Sweden
- Switzerland
- Denmark
- Finland
- Russia
- Rest of Europe
- The Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Indonesia
- Taiwan
- Malaysia
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- The Middle East
- Africa